NDC 55289-920-90
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-90
- Package NDCs from labels
- 55289-920-90
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nifedipine | NIFEDIPINE | PD-Rx Pharmaceuticals, Inc. | 75003769-7800-4bc7-b709-35b4caec2c2f | 2025-03-17 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | c37206ae-52f1-4192-9ab9-3044247cf58d | 2025-03-13 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| FOLIC ACID | FOLIC ACID | PD-Rx Pharmaceuticals, Inc. | 726bb436-69e3-452f-9f28-153b58bf3ca5 | 2025-03-13 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ibuprofen | IBUPROFEN | PD-Rx Pharmaceuticals, Inc. | ce5b0429-bbe1-47a4-af5e-0159d3cfd2c3 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Estradiol | ESTRADIOL | PD-Rx Pharmaceuticals, Inc. | d0d1c2c8-b175-4250-9343-d7db65b72e8f | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Penicillin V Potassium | PENICILLIN V POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 7aef4c8b-aee7-453d-bb6f-fce8e4588e3b | 2025-03-13 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | PD-Rx Pharmaceuticals, Inc. | add10ccd-c205-4512-9619-253290fa1152 | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9c8ced4b-94de-4df8-bea3-b42b8846b769 | 2025-03-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | ac86821f-d741-4ab1-bd03-ce8797dd4f34 | 2025-03-12 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Diclofenac Potassium | DICLOFENAC POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 08e41a9d-644c-4ac6-aba3-38d7c3f36d36 | 2025-03-07 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0c021aad-97a3-4404-a11e-cdd2ec731c6b | 2025-03-07 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Benazepril Hydrochloride | BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 1a7b373a-9b74-4b9d-93fb-081614222e30 | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Benazepril Hydrochloride | BENAZEPRIL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 355811f0-2885-0d49-e054-00144ff8d46c | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | 70e2bf86-4a78-4dfb-b6b1-8eb95f63684d | 2025-03-06 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| MECLIZINE | MECLIZINE HCL 25MG | PD-Rx Pharmaceuticals, Inc. | cf79ac74-017e-4fb4-85d3-4ea944080e89 | 2025-03-06 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | c2177034-e164-453c-be02-1cf91ce27a07 | 2025-02-28 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | eea93a4b-f804-4b9c-aabf-e906f03c1e80 | 2025-02-28 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Cefadroxil | CEFADROXIL | PD-Rx Pharmaceuticals, Inc. | f5bbbf87-f059-4bbd-aea9-27d31462654f | 2025-02-28 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 0ffcdbab-17e4-4395-8155-5b6ad00be6c2 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | Alprazolam ALPRAZOLAM PD-Rx Pharmaceuticals, Inc. |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3a319017-4e25-402e-8ba0-63b9f1eb707e | 2025-02-27 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.